Treatment of cutaneous T cell lymphoma with 2′-deoxycoformycin (pentostatin)
- 31 October 1988
- journal article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 19 (4), 692-698
- https://doi.org/10.1016/s0190-9622(88)70224-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effectiveness of Pentostatin (2‘-Deoxycoformycin) in Refractory Lymphoid NeoplasmsScandinavian Journal of Haematology, 2009
- Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal PhotochemotherapyNew England Journal of Medicine, 1987
- Cutaneous T Cell LymphomaMedical Clinics of North America, 1986
- Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminaseBritish Journal of Haematology, 1984
- An investigation of 2'-deoxycoformycin in the treatment of cutaneous T- cell lymphomaBlood, 1983
- Treatment of lymphoid malignancies with 2'-deoxycoformycin A pilot studyAmerican Journal of Clinical Oncology, 1982
- Inhibitors of adenosine deaminasePharmacology & Therapeutics, 1982
- Clinical pharmacology of deoxycoformycinBlood, 1981
- Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia.JCI Insight, 1978
- A study of the tissue distribution of adenosine deaminase in six mammal speciesComparative Biochemistry and Physiology, 1965